37662-0707 : Erigeron Canadensis 200 [Hp_c]/1 Oral Pellet


NDC: 37662-0707
Labeler: Hahnemann Laboratories, Inc.
Product Type: Human OTC Drug
Drug Name: Erigeron Canadensis
Dosage Form: Oral Pellet
Rev. Date: 


NDC Package Codes:

  • 37662-0707-1: 200 PELLET IN 1 VIAL, GLASS (37662‑0707‑1)
  • 37662-0707-2: 500 PELLET IN 1 VIAL, GLASS (37662‑0707‑2)
  • 37662-0707-3: 3000 PELLET IN 1 BOTTLE, GLASS (37662‑0707‑3)
  • 37662-0707-4: 10000 PELLET IN 1 BOTTLE, GLASS (37662‑0707‑4)

Active Ingredients:

  • Erigeron Canadensis

Dosage Strength:

  • 200 [hp_C]/1

Related Products:

Based on records with the same trade name.
  • 37662-0703 Erigeron Canadensis 6 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-0704 Erigeron Canadensis 12 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-0705 Erigeron Canadensis 30 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-0706 Erigeron Canadensis 100 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-0708 Erigeron Canadensis 500 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-0709 Erigeron Canadensis 1 [Hp_m]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-0710 Erigeron Canadensis 1 [Hp_q]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 0220-1900 Erigeron Canadensis 30 [Hp_c]/30[hp_c] Oral Pellet by Boiron
  • 15631-0180 Erigeron Canadensis 1 [hp_x]/1 Oral Pellet by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc
  • 68428-369 Erigeron Canadensis 30 [Hp_c]/1 Oral Pellet by Washington Homeopathic Products

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 37662-0707 QR Code

< Prev: 37662-0706Next: 37662-0708 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.